Cogent Biosciences Stock 346% Surge Fueled by New Stake
A Phase 3 breakthrough unleashed a dramatic move in Cogent Biosciences. A large fund followed with a sizable stake, s...
Categorizing expenses clarifies where money goes, helping you spot trends and reallocate funds toward essential goals.
12,229 articlesA Phase 3 breakthrough unleashed a dramatic move in Cogent Biosciences. A large fund followed with a sizable stake, s...
Is there a true housing shortage in the United States, or is the story driven by location, price, and policy? This ar...
Ford's China negotiations could redefine its growth trajectory. This article explains the real reason investors shoul...
A public feud over college’s worth heats up in 2026 as Peter Thiel backs alternatives with large grants. The former g...
A Utah mother of three stands trial for murder after a year of tragedy, with prosecutors alleging a fentanyl-linked d...
Can Lumen Technologies stock your journey toward wealth? This article breaks down the company’s shift toward AI infra...
As AI reshapes tech and business, where will Nvidia stock be in 2030? This guide breaks down drivers, risks, and prac...
Mega-cap tech values are under pressure, and the question on many minds is whether Alphabet, Apple, Microsoft kicked ...
Costco and Walmart are two retail giants with different strengths. This guide breaks down which could be the best con...
Tariff headlines keep markets guessing. This guide shows how two Vanguard index funds outperformed the S&P 500 in 202...
This article breaks down Summit Hotel (Inn) earnings, translating quarterly results into actionable insights for inve...
Bitcoin slides roughly 3% after hotter-than-expected January PPI data; a surge in services inflation is prompting a f...